Skip to main content
CNBX logo

CNBX · CNBX Pharmaceuticals Inc. · Shareholders & Ownership

Track CNBX — free
$0.00 +0.00 (+0.00%) At close · Oct 22
Market Cap
$160,576
Shares
1.61B
Volume · Oct 22 70.04M Avg daily vol (3M) 5.6M

Every disclosed holder of CNBX in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns CNBX

13F quarter Dec 31, 2024
Holder group Shares % Out
Institutional (13F) 9 0.00%
Insiders (Forms 3, 4, 5) 0 0.00%
13D/G-only blocks 169,341,400 10.55%
Remaining 1,436,426,686 89.45%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 1,605,768,095, the issuer's latest cover-page count restated onto today's split basis.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of CNBX

# Holder Shares
1
3i, LP
13G CIK 1841619 · Unknown · Jun 30, 2026
Rule 13d-1(c), passive investor
169,341,400
2
Archer Investment Corp
13F CIK 1803804 · Registered investment adviser · Dec 31, 2024
9

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1343009 CUSIP 13764M209 Visit website Investor relations